Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oryzon Genomics SA
ORYCurrent price
1.67 EUR
-0.004 EUR (-0.24%)
Last closed
1.63 EUR
Company
www.oryzon.com
ISIN
ES0167733015
Sector
Healthcare
Industry
Biotechnology
Exchange
Madrid Exchange
Capitalization
103 999 073 EUR
Yield for 12 month
-17.52 %
1Y
3Y
5Y
10Y
15Y
ORY
Oryzon Genomics S.A., a clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases. The company was founded in 2000 and is based in Cornellà de Llobregat, Spain. Address: Sant Ferran 74, Cornellà de Llobregat, Spain, 08940
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.38 EURP/E ratio
–Dividend Yield
–Current Year
+14 361 561 EUR
Last Year
–
Current Quarter
–
Last Quarter
+4 156 512 EUR
Current Year
+28 476 505 EUR
Last Year
+15 416 594 EUR
Current Quarter
–
Last Quarter
+3 983 995 EUR
Key Figures ORY
1 year
3 years
5 years
10 years
EBITDA
92 954 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-2.64 %
PEG Ratio
–
Return On Equity TTM
-4.64 %
Wall Street Target Price
7.38 EUR
Revenue TTM
16 017 808 EUR
Book Value
1.36 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-45.1 %
Dividend Yield
–
Gross Profit TTM
15 416 594 EUR
Earnings per share
-0.071 EUR
Diluted Eps TTM
-0.071 EUR
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-89.5 %
Profit Margin
-28.78 %
Dividend Analytics ORY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ORY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ORY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
9.2937
Enterprise Value Revenue
–
Price Sales TTM
6.4927
Enterprise Value EBITDA
127.2609
Price Book MRQ
1.0611
Financials ORY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ORY
For 52 weeks
1.57 EUR
2.41 EUR
50 Day MA
1.81 EUR
Shares Short Prior Month
–
200 Day MA
1.87 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart